Verastem, Inc. Investment Owned, at Cost
Verastem, Inc. (VSTM) had Investment Owned, at Cost of $86.82 million as of 2016-09-30, per its 10-Q filed 2016-11-07.
Discontinued › Notes
us-gaap:InvestmentOwnedAtCost · last filed 2016-11-07
- 2016-09-30: Investment Owned, at Cost $86.82M.
- 2016-06-30: Investment Owned, at Cost $92.79M.
- 2016-03-31: Investment Owned, at Cost $99.40M.
- 2015-12-31: Investment Owned, at Cost $110.22M.
| Period end | Investment Owned, at Cost | Investment Owned, at Cost as first filed |
|---|---|---|
| 2016-09-30 | $86.82M 10-Q · filed 2016-11-07 | |
| 2016-06-30 | $92.79M 10-Q · filed 2016-08-08 | |
| 2016-03-31 | $99.40M 10-Q · filed 2016-05-09 | |
| 2015-12-31 | $110.22M 10-Q · filed 2016-11-07 | |
| 2015-09-30 | $120.42M 10-Q · filed 2015-11-09 | |
| 2015-06-30 | $132.06M 10-Q · filed 2015-08-10 | |
| 2015-03-31 | $136.03M 10-Q · filed 2015-05-11 | |
| 2014-12-31 | $92.66M 10-K · filed 2016-03-03 | |
| 2014-09-30 | $93.34M 10-Q · filed 2014-10-30 | |
| 2014-06-30 | $104.32M 10-Q · filed 2014-08-07 | |
| 2014-03-31 | $113.85M 10-Q · filed 2014-05-08 | |
| 2013-12-31 | $123.63M 10-K · filed 2015-03-10 | |
| 2013-09-30 | $130.19M 10-Q · filed 2013-11-12 | |
| 2013-06-30 | $78.01M 10-Q · filed 2013-08-13 | |
| 2013-03-31 | $84.40M 10-Q · filed 2013-05-09 | |
| 2012-12-31 | $91.50M 10-K · filed 2014-03-06 | $91.50M 10-K · filed 2013-03-26 |
| 2012-09-30 | $97.41M 10-Q · filed 2012-11-13 | |
| 2012-06-30 | $104.30M 10-Q · filed 2012-08-13 | |
| 2011-12-31 | $56.81M 10-K · filed 2013-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 |